Tuesday, August 3, 2010: 1:00 PM-4:30 PM
Bayview B (Hyatt Regency San Francisco)
Chair:
Carlos Martinez
1:00 PM
A strategy for the production of drug metabolites based on bacterial cytochrome P450s—Challenges and solutions
Uwe Christians, University of Colorado , Denver, CO
Uwe Christians, University of Colorado , Denver, CO
1:30 PM
Codex™ MicroCyp plate for drug metabolite production and lead diversification
Erik de Vries, Codexis, Inc., Redwood City, CA
Erik de Vries, Codexis, Inc., Redwood City, CA
2:00 PM
Metabolizing enzyme microarray to generate metabolites for early toxicity screening
David Rozzell, Solidus Inc., Troy, NY
David Rozzell, Solidus Inc., Troy, NY
3:00 PM
Drug metabolite synthesis with biocatalysts-challenge, strategy and impact
Wenying Li, Bristol-Myers Squibb R&D, Princeton, NJ
Wenying Li, Bristol-Myers Squibb R&D, Princeton, NJ
3:30 PM
Fungal transformation of xenobiotics
Carl E. Cerniglia, Microbiology, FDA/National Center for Toxicological Research, Jefferson, AR
Carl E. Cerniglia, Microbiology, FDA/National Center for Toxicological Research, Jefferson, AR
See more of: Invited Oral Papers